Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-289614
Filing Date
2022-11-21
Accepted
2022-11-21 10:05:00
Documents
4
Period of Report
2022-11-21

Document Format Files

Seq Description Document Type Size
1 6-K d613490d6k.htm 6-K 8934
2 EX-99.1 d613490dex991.htm EX-99.1 19693
3 GRAPHIC g613490g1110193614921.jpg GRAPHIC 1087
4 GRAPHIC g613490g1121160017797.jpg GRAPHIC 2601
  Complete submission text file 0001193125-22-289614.txt   35186
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 221403889
SIC: 2834 Pharmaceutical Preparations